Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Portfolio Pulse from Avi Kapoor
Jabil Inc. shares fell over 14% after reporting Q2 results and FY25 guidance below estimates. Other stocks also showed significant movement, with notable gainers including Verb Technology and Better Therapeutics, and losers like C3is Inc. and SELLAS Life Sciences.
March 15, 2024 | 6:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
C3is Inc. shares plummeted 62.5% following the announcement of a $6 million underwritten public offering.
C3is Inc.'s significant stock price drop is a reaction to the announcement of a public offering, which often leads to concerns about share dilution among investors.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Jabil Inc. shares dropped 14.2% after Q2 earnings beat but sales missed estimates and FY25 guidance disappointed.
Jabil's share price drop is directly related to its Q2 earnings report and future guidance, which failed to meet market expectations, particularly in sales and FY25 outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
SELLAS Life Sciences shares fell 34.8% after announcing a $20 million offering and concurrent private placement.
SELLAS Life Sciences' stock price decline is linked to its announcement of a significant offering and private placement, raising concerns about dilution.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Verb Technology shares surged 189% after launching Facebook and Instagram social shopping technology integration.
The significant surge in Verb Technology's stock price is attributed to the launch of a promising social shopping technology, indicating strong market approval.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90